LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 28 Jul 2015
Print article
The Power Express automation solution
The Power Express automation solution (Photo courtesy of BECKMAN COULTER, INC - Danaher)
Top-of-the-line automated diagnostic systems are highlighted in Booth 2409 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Beckman Coulter Diagnostics (Brea, CA, USA) is displaying its state-of-the-art laboratory instruments at this year's meeting. Particular emphasis is being placed on the Power Express automation system for general clinical chemistry and the MicroScan WalkAway system for the microbiology lab.

Power Express is a connected clinical automation solution that consolidates all core disciplines—chemistry, immunochemistry, hematology, and coagulation—into a single automated line. Power Express performs multiple functions including sample login, centrifugation, decapping, aliquotting, presentation of samples for connected instruments, recapping, storing in ambient or refrigerated storage modules, and sorting to outlets. Intelligent sample management reduces variability and increases predictability because dynamic sample routing is based on test ordered and analyzers availability. Samples can crisscross and loop-back on track to analyzers, and smart carrier management ensures that high-throughput analyzers are optimized. Barcode sample reading at each sample aspiration maintains accuracy with positive patient identification.

The WalkAway plus microbiology system is the fourth generation of proven WalkAway technology and reliability. This platform delivers gold-standard accuracy for microorganism identification and susceptibility testing. It enables simultaneous processing of conventional, rapid, and specialty panels on a single, automated platform and delivers accurate resistance detection for emerging pathogens, including VISA, VRSA, and MRSA. The WalkAway plus System includes LabPro Information Management software designed to simplify workflow and minimize technologist interaction while accommodating differing regional and institutional environments through extensive customization features.

Visitors to the Beckman Coulter Diagnostics booth will be shown how the company is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity while minimizing errors and reducing turnaround time to improve physician confidence.

“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
Beckman Coulter Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more